The U.S. Supreme Court on Thursday rejected the Trump administration’s request to lift a district‑court injunction that bars the denial of gender‑affirming medical care to transgender prisoners in federal facilities. The high court’s denial means hormone therapy, puberty blockers and related treatments will continue for incarcerated trans individuals while the underlying lawsuit proceeds.
Policy background
In August 2022, the Department of Justice, under former President Donald Trump, issued a policy directing the Federal Bureau of Prisons to discontinue “sex‑reassignment” procedures for transgender inmates, arguing that such care was costly, unnecessary and posed security risks. The rule sought to halt hormone‑replacement therapy, puberty‑blocking drugs and related surgeries for prisoners, effectively ending gender‑affirming care in the federal prison system.
Three transgender inmates, joined by advocacy groups, sued the government, contending that the policy violated the Equal Protection Clause and the Prisoners’ Rights Act. A federal district judge in Washington, D.C., issued a nationwide preliminary injunction in February 2023, preventing the rule’s enforcement. The administration appealed directly to the Supreme Court for emergency relief.
Court ruling and implications
The Supreme Court, in an unsigned order, denied the administration’s request for an emergency stay. While the decision was not a full hearing on the merits, it upheld the status‑quo, preserving the lower‑court injunction. The order was joined by seven justices; Justices Clarence Thomas and Samuel Alito filed a brief dissent, arguing that the Court should have granted the stay pending a full review.
"The Court refuses to lift the injunction, allowing transgender inmates to continue receiving hormone therapy and related care while the case proceeds," Reuters reported.
Legal analysts described the outcome as a “rare defeat” for the Trump administration, which has faced multiple setbacks in the Court since leaving office. The ruling underscores the judiciary’s willingness to scrutinize policies that intersect with medical autonomy and civil‑rights protections.
LGBTQ advocacy groups hailed the decision as a victory for trans rights and prison health standards. The National Prison Project of the Prisoners’ Rights Center said the order “reinforces the principle that incarcerated individuals retain the right to necessary medical treatment.” The Justice Department, meanwhile, said it would continue to explore “alternative, evidence‑based approaches” to address the administration’s concerns about costs and safety.
International observers note that the case reflects broader global debates over the provision of gender‑affirming care in correctional settings. The United Nations has urged member states to ensure that prisoners receive health services consistent with recognized human‑rights standards, making the U.S. decision relevant to ongoing discussions about prison reform and LGBTQ rights worldwide.
